Clinical Trials Browser

Phase 2 × INDUSTRY × Persistent Infection × Clear all

NCT02740777 2023-04-13

Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females

Phase 2 Completed

Persistent Infection, Uterine Cervical Dysplasia